Upcoming changes for home infusion therapy and ambulatory infusion center providers

Beginning Jan. 1, 2019, home infusion therapy and ambulatory infusion center providers can submit payable procedure codes for rendered services from the list below:

Procedure code	Drug name
*90284	Immune globulin (SCIg)
*90399	Immune globulin
J0638	Canakinumab, 1 mg
J0717	Certolizumab pegol, 1 mg
J0897	Denosumab, 1 mg
J1290	Ecallantide, 1 mg
J1744	Icatibant, 1 mg
J2182	Mepolizumab, 1 mg
J2357	Omalizumab, 5 mg
J2504	Pegademase bovine, 25 IU
J3357	Ustekinumab, 1 mg

Select injectable medications will be payable in the home setting and ambulatory infusion centers without requiring medical IV therapy on the same day.

Note: The billing requirement to include the National Drug Code, or NDC, and quantity remains in place.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2017 American Medical Association. All rights reserved.